Bora Pharmaceuticals Co., LTD. (TPE:6472)
Taiwan
· Delayed Price · Currency is TWD 733.00
+25.00 (3.53%)
May 14, 2025, 1:30 PM CST
TPE:6472 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | May '25 May 13, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 75,655 | 77,712 | 64,612 | 31,121 | 12,446 | 10,634 | Upgrade
|
| Market Cap Growth | 5.12% | 20.27% | 107.61% | 150.04% | 17.05% | 89.60% | Upgrade
|
| Enterprise Value | 90,855 | 92,091 | 67,752 | 36,584 | 13,828 | 11,299 | Upgrade
|
| Last Close Price | 733.00 | 752.00 | 629.21 | 311.25 | 123.77 | 105.34 | Upgrade
|
| PE Ratio | 20.46 | 19.73 | 21.32 | 22.36 | 16.60 | 18.38 | Upgrade
|
| Forward PE | 18.47 | 16.07 | 21.03 | 11.57 | 14.97 | 21.75 | Upgrade
|
| PS Ratio | 3.93 | 4.04 | 4.55 | 2.97 | 2.54 | 5.91 | Upgrade
|
| PB Ratio | 5.04 | 5.18 | 5.49 | 6.05 | 3.95 | 4.31 | Upgrade
|
| P/TBV Ratio | 13.95 | 14.33 | 18.95 | 13.07 | 4.18 | 4.32 | Upgrade
|
| P/FCF Ratio | 167.12 | 171.66 | 14.97 | 17.14 | 11.60 | 372.33 | Upgrade
|
| P/OCF Ratio | 77.14 | 79.23 | 14.01 | 15.48 | 10.07 | 59.81 | Upgrade
|
| EV/Sales Ratio | 4.72 | 4.79 | 4.77 | 3.49 | 2.82 | 6.28 | Upgrade
|
| EV/EBITDA Ratio | 20.88 | 21.72 | 11.82 | 16.87 | 11.42 | 31.90 | Upgrade
|
| EV/EBIT Ratio | 26.86 | 27.23 | 12.91 | 19.03 | 13.22 | 49.98 | Upgrade
|
| EV/FCF Ratio | 200.69 | 203.42 | 15.70 | 20.15 | 12.89 | 395.62 | Upgrade
|
| Debt / Equity Ratio | 1.09 | 1.26 | 0.42 | 1.48 | 0.70 | 1.17 | Upgrade
|
| Debt / EBITDA Ratio | 3.92 | 4.36 | 0.86 | 3.44 | 1.80 | 7.88 | Upgrade
|
| Debt / FCF Ratio | 29.53 | 41.91 | 1.16 | 4.18 | 2.07 | 100.89 | Upgrade
|
| Asset Turnover | 0.54 | 0.54 | 0.59 | 0.70 | 0.68 | 0.35 | Upgrade
|
| Inventory Turnover | 3.92 | 3.01 | 3.48 | 5.19 | 3.16 | 1.56 | Upgrade
|
| Quick Ratio | 1.04 | 1.26 | 0.91 | 0.95 | 0.96 | 0.61 | Upgrade
|
| Current Ratio | 1.42 | 1.71 | 1.29 | 1.17 | 1.52 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 45.45% | 30.18% | 36.34% | 33.80% | 26.69% | 28.09% | Upgrade
|
| Return on Assets (ROA) | 5.12% | 5.98% | 13.70% | 7.97% | 9.10% | 2.72% | Upgrade
|
| Return on Capital (ROIC) | 7.60% | 8.33% | 22.25% | 13.27% | 12.20% | 3.36% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.10% | 10.60% | 31.10% | 15.70% | 18.90% | 4.80% | Upgrade
|
| Earnings Yield | 5.21% | 5.07% | 4.69% | 4.47% | 6.02% | 5.44% | Upgrade
|
| FCF Yield | 0.60% | 0.58% | 6.68% | 5.83% | 8.62% | 0.27% | Upgrade
|
| Dividend Yield | 1.98% | 1.86% | 1.91% | 1.98% | 1.98% | 1.07% | Upgrade
|
| Payout Ratio | 31.30% | 31.30% | 20.43% | 17.16% | 14.64% | 14.39% | Upgrade
|
| Buyback Yield / Dilution | -8.17% | -8.17% | -4.93% | -1.41% | -0.86% | -7.55% | Upgrade
|
| Total Shareholder Return | -6.19% | -6.31% | -3.02% | 0.57% | 1.12% | -6.49% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.